Company intelligence / Profile preview

KNK-DONACARE

Ho Chi Minh City, Vietnam

Ownership: Private
Development stage: Other

Overview

KNK-DONACARE is a pharmaceutical entity primarily focused on the commercialization of treatments for joint health and musculoskeletal disorders. The company's flagship product is Donacare, a formulation of crystalline glucosamine sulfate used for the symptomatic relief of osteoarthritis. KNK-DONACARE operates within the Southeast Asian market, providing high-quality therapeutic options to manage pain and improve mobility in patients with degenerative joint diseases. Their business model centers on the distribution and marketing of established pharmaceutical ingredients with proven clinical efficacy in bone and joint care.

Therapeutic areas: Rheumatology
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on KNK-DONACARE.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on KNK-DONACARE.

Explore the full profile